|
CN111879507A
|
|
Setting pressure detection device, method and system of safety valve
|
|
WO2021004388A1
|
|
Crystal form of sglt inhibitor and application thereof
|
|
WO2020125776A1
|
|
Process route of compound of formula (iv), crystal form and preparation method therefor
|
|
WO2020088677A1
|
|
Angiotensin ii receptor 2 antagonist salt form and crystalline form, and preparation method therefor
|
|
KR20200106156A
|
|
SGLT inhibitors and their applications
|
|
CN111206084A
|
|
MiRNA related to treatment of chronic stable angina pectoris and application thereof
|
|
US2020188342A1
|
|
Sustained release suspension containing dezocine analogue ester and preparation method therefor
|
|
CN110891929A
|
|
Crystalline and amorphous forms of dezocine analog hydrochloride
|
|
EP3620454A1
|
|
Carboxylic acid derivative as at2r receptor antagonist
|
|
CN108992672A
|
|
A kind of wogonin pharmaceutical composition for treating neoplastic disease
|
|
CN108602757A
|
|
Dezocine analog
|
|
CN106420694A
|
|
Pharmaceutical composition for preventing and treating cardiovascular diseases
|
|
CN104964939A
|
|
Method for detecting content of sodium and potassium ions in Danhong injection
|
|
CN105021724A
|
|
Danhong injection UPLC fingerprint detection method
|
|
CN103940929A
|
|
Method for detecting traditional Chinese medicine injection for treating cardiovascular and cerebrovascular diseases
|
|
CN103926364A
|
|
Fingerprint spectrum determination method for traditional Chinese medicine injection solution for treating cardiovascular and cerebrovascular diseases
|
